751 related articles for article (PubMed ID: 22234884)
21. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
22. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
23. Stents versus coronary-artery bypass grafting for left main coronary artery disease.
Seung KB; Park DW; Kim YH; Lee SW; Lee CW; Hong MK; Park SW; Yun SC; Gwon HC; Jeong MH; Jang Y; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
N Engl J Med; 2008 Apr; 358(17):1781-92. PubMed ID: 18378517
[TBL] [Abstract][Full Text] [Related]
24. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
[TBL] [Abstract][Full Text] [Related]
25. Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: a comparative effectiveness study based on propensity score-matched cohorts.
Fortuna D; Nicolini F; Guastaroba P; De Palma R; Di Bartolomeo S; Saia F; Pacini D; Grilli R; ;
Eur J Cardiothorac Surg; 2013 Jul; 44(1):e16-24. PubMed ID: 23628951
[TBL] [Abstract][Full Text] [Related]
26. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry).
Leitner J; Vlachos HA; Selzer F; Jamal SM; Kip KE; Williams DO; Abbott JD
Am J Cardiol; 2012 Feb; 109(4):466-70. PubMed ID: 22118825
[TBL] [Abstract][Full Text] [Related]
28. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
[TBL] [Abstract][Full Text] [Related]
29. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
[TBL] [Abstract][Full Text] [Related]
30. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
[TBL] [Abstract][Full Text] [Related]
31. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
32. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
[TBL] [Abstract][Full Text] [Related]
33. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
[TBL] [Abstract][Full Text] [Related]
34. Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study.
Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Her SH; Hur SH; Park JS; Kim MK; Choi YS; Kim HS; Cho JH; Lee SG; Park YW; Jeong MH; Lee BK; Lee NH; Lim DS; Yoon J; Seung KB; Shin WY; Rha SW; Kim KS; Tahk SJ; Park BE; Ahn T; Yang JY; Jeong YS; Rhew JH; Park SJ;
Circ Cardiovasc Interv; 2012 Jun; 5(3):365-71. PubMed ID: 22693347
[TBL] [Abstract][Full Text] [Related]
35. A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study.
Han YL; Zhang L; Yang LX; Liu HL; Qu P; Li WM; Jiang TM; Li SM; Jing QM; Zhang QY; Xu B; Li Y; Gao RL
EuroIntervention; 2012 Nov; 8(7):815-22. PubMed ID: 23171802
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
37. Impact of gender on long-term mortality in patients with unprotected left main disease: The Milan and New-Tokyo (MITO) Registry.
Takagi K; Chieffo A; Shannon J; Naganuma T; Tahara S; Fujino Y; Latib A; Montorfano M; Carlino M; Kawamoto H; Nakamura S; Colombo A
Cardiovasc Revasc Med; 2016 Sep; 17(6):369-74. PubMed ID: 27460302
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience.
Chieffo A; Morici N; Maisano F; Bonizzoni E; Cosgrave J; Montorfano M; Airoldi F; Carlino M; Michev I; Melzi G; Sangiorgi G; Alfieri O; Colombo A
Circulation; 2006 May; 113(21):2542-7. PubMed ID: 16717151
[TBL] [Abstract][Full Text] [Related]
39. Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients.
Kim YH; Park DW; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ;
EuroIntervention; 2013 May; 9(1):110-7. PubMed ID: 23685299
[TBL] [Abstract][Full Text] [Related]
40. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.
Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
